Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Deciphera Pharmaceuticals, Inc. (DCPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 2,942 shares @ $12.68, valued at $37.3k
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
Docs: "Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results"
08/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Deciphera Pharmaceuticals Announces Retirement of Daniel L. Flynn, Ph.D., and Appointment of Dashyant Dhanak, Ph.D., as Executive Vice President and Chief Scientific Officer"
06/12/2023 4 Friedman Franklin Stuart (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Bought 10,000 shares @ $13.8828, valued at $138.8k
05/03/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
05/03/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/03/2023 8-K Quarterly results
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/23/2023 4 Hoerter Steven L. (President and CEO) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 7,500 shares @ $15.5709, valued at $116.8k
03/22/2023 SC 13G Flynn James E reports a 6.1% stake in Deciphera Pharmaceuticals, Inc.
03/01/2023 4 Brightstar Associates LLC (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 2,427,693 warrants @ $0.01, valued at $24.3k
02/14/2023 SC 13G BRAIDWELL LP reports a 6.7% stake in DECIPHERA PHARMACEUTICALS INC
02/14/2023 SC 13G/A ARMISTICE CAPITAL, LLC reports a 7.6% stake in DECIPHERA PHARMACEUTICALS, INC.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Flynn James E reports a 3.5% stake in Deciphera Pharmaceuticals, Inc.
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 7% stake in Deciphera Pharmaceuticals Inc.
02/08/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2023 SC 13G/A GOLDMAN SACHS GROUP INC reports a 5.7% stake in DECIPHERA PHARMACEUTICALS, INC.
02/07/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/07/2023 10-K Annual Report for the period ended December 31, 2022
02/07/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results"
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/24/2023 4 Brightstar Associates LLC (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Bought 1,666,666 shares @ $18, valued at $30M
01/20/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement",
"Opinion of Goodwin Procter LLP"
01/20/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
01/19/2023 4 Friedman Franklin Stuart (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 3,269 options to buy @ $21.27, valued at $69.5k
01/19/2023 4 Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 2,403 shares @ $21.2413, valued at $51k
01/19/2023 4 Pitman Jama (See Remarks) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 1,603 shares @ $21.2413, valued at $34k
01/19/2023 4 Sherman Matthew L (EVP & Chief Medical Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Sold 2,403 shares @ $21.2413, valued at $51k
01/19/2023 4 Allen Patricia L (Director) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.
Txns: Granted 3,269 options to buy @ $21.27, valued at $69.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy